Sundquist, F; Georgantzi, K; Jarvis, KB; Brok, J; Koskenvuo, M; Rascon, J; van Noesel, M; ... Stenman, J; + view all (2022) A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma–LuDO-N. Frontiers in Pediatrics , 10 , Article 836230. 10.3389/fped.2022.836230. Green open access